Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Musto

Showing results (71-80 of 112) with videos related to

Pageof 12
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2009
Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending storyA Bari, L Marcheselli, S Sacchi, et al.
Blood|May 16, 1998
Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcomeG Nadali, L Tavecchia, E Zanolin, et al.
International Journal of Immunopathology and Pharmacology|March 27, 2013
Regulatory T-cell modulation by green tea in chronic lymphocytic leukemiaG D'Arena, V Simeon, L De Martino, et al.
Bone Marrow Transplantation|July 1, 1996
Effective autologous peripheral blood stem cell transplantation in plasma cell leukemia followed by T-large granular lymphocyte expansion: a case reportM R Sajeva, M M Greco, N Cascavilla, et al.
Leukemia|July 1, 1996
Hepatitis C virus infection and monoclonal gammopathies not associated with cryoglobulinemiaA Mangia, R Clemente, P Musto, et al.
British Journal of Haematology|February 1, 1997
Conventional induction treatments do not influence overall survival in multiple myelomaM Boccadoro, A Palumbo, C Argentino, et al.
Leukemia Research|February 13, 2010
Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelinesV Santini, P E Alessandrino, E Angelucci, et al.
Blood|February 13, 2001
Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin diseaseL Teofili, A L Di Febo, F Pierconti, et al.
Haematologica|October 6, 1999
An analysis of which subgroups of multiple myeloma patients, divided according to b(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapyM Boccadoro, C Tarella, A Palumbo, et al.
Annals of Surgery|February 27, 2001
Pancreas resection and islet autotransplantation for end-stage chronic pancreatitisS A White, J E Davies, C Pollard, et al.
Pageof 12

Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2009
Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending storyA Bari, L Marcheselli, S Sacchi, et al.
Blood|May 16, 1998
Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcomeG Nadali, L Tavecchia, E Zanolin, et al.
International Journal of Immunopathology and Pharmacology|March 27, 2013
Regulatory T-cell modulation by green tea in chronic lymphocytic leukemiaG D'Arena, V Simeon, L De Martino, et al.
Bone Marrow Transplantation|July 1, 1996
Effective autologous peripheral blood stem cell transplantation in plasma cell leukemia followed by T-large granular lymphocyte expansion: a case reportM R Sajeva, M M Greco, N Cascavilla, et al.
Leukemia|July 1, 1996
Hepatitis C virus infection and monoclonal gammopathies not associated with cryoglobulinemiaA Mangia, R Clemente, P Musto, et al.
British Journal of Haematology|February 1, 1997
Conventional induction treatments do not influence overall survival in multiple myelomaM Boccadoro, A Palumbo, C Argentino, et al.
Leukemia Research|February 13, 2010
Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelinesV Santini, P E Alessandrino, E Angelucci, et al.
Blood|February 13, 2001
Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin diseaseL Teofili, A L Di Febo, F Pierconti, et al.
Haematologica|October 6, 1999
An analysis of which subgroups of multiple myeloma patients, divided according to b(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapyM Boccadoro, C Tarella, A Palumbo, et al.
Annals of Surgery|February 27, 2001
Pancreas resection and islet autotransplantation for end-stage chronic pancreatitisS A White, J E Davies, C Pollard, et al.
Pageof 12